Stratipath Breast

Categories

Description

AI-based prognostic risk profiling tool for breast cancer tissue analysis.

Summary

Stratipath Breast is an AI-powered tool designed for the prognostic risk profiling of breast cancer, capable of identifying patients with varying risks of disease progression. It analyzes cancer tissue to provide insights into the likelihood of disease advancement, offering a quicker and less costly alternative to gene expression testing. This tool is integrated into clinical workflows, providing results that can significantly impact treatment decisions.

Use Cases

• Clinicians use Stratipath Breast to quickly assess the risk of breast cancer progression, facilitating timely treatment decisions.
• Pathologists integrate Stratipath Breast into their workflow for an objective, AI-driven assessment of breast cancer risk.